MiR-296
| miR-296 | |
|---|---|
 | |
| Conserved secondary structure of miR-296 microRNA precursor | |
| Identifiers | |
| Symbol | miR-296 |
| Alt. Symbols | MIR296 |
| Rfam | RF00733 |
| miRBase | MI0000747 |
| miRBase family | MIPF0000159 |
| Entrez | 407022 |
| HUGO | 31617 |
| OMIM | 610945 |
| RefSeq | NR_029844 |
| Other data | |
| RNA type | miRNA |
| Domain(s) | Mammalia |
| GO | 0035195 |
| SO | 0001244 |
| Locus | Chr. 20 q13.32 |
miR-296 is a family of microRNA precursors found in mammals, including humans. The ~22 nucleotide mature miRNA sequence is excised from the precursor hairpin by the enzyme Dicer.[1] This sequence then associates with RISC which effects RNA interference.[2]
miR-296 has been named an "angiomiR"[3] due to being characterised as a microRNA which regulates angiogenesis, the process of growth and creation of new blood vessels.[4] miR-296 is thought to have a specific role in cancer in promoting tumour angiogenesis.[3][5] It achieves this by targeting HGS mRNA, reducing its expression in endothelial cells which then results in greater number of VEGF receptors.[3][6]
miR-296 has predicted target sites in the transcription factor NANOG[7] and may also contribute to carcinogenesis by dysregulating p53.[8]
References
- ↑ Ambros, V (2001-12-28). "microRNAs: tiny regulators with great potential.". Cell 107 (7): 823–6. doi:10.1016/S0092-8674(01)00616-X. PMID 11779458.
- ↑ Gregory, RI; Chendrimada, TP, Cooch, N, Shiekhattar, R (2005-11-18). "Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.". Cell 123 (4): 631–40. doi:10.1016/j.cell.2005.10.022. PMID 16271387.
- ↑ 3.0 3.1 3.2 Wang, S; Olson, EN (June 2009). "AngiomiRs--key regulators of angiogenesis". Current Opinion in Genetics & Development 19 (3): 205–11. doi:10.1016/j.gde.2009.04.002. PMC 2696563. PMID 19446450.
- ↑ Anand, S; Cheresh, DA (May 2011). "MicroRNA-mediated regulation of the angiogenic switch". Current Opinion in Hematology 18 (3): 171–6. doi:10.1097/MOH.0b013e328345a180. PMC 3159578. PMID 21423013. (subscription required)
- ↑ Bonauer, A; Boon, RA, Dimmeler, S (August 2010). "Vascular microRNAs". Current drug targets 11 (8): 943–9. doi:10.2174/138945010791591313. PMID 20415654.
- ↑ Würdinger, T; Tannous, BA, Saydam, O, Skog, J, Grau, S, Soutschek, J, Weissleder, R, Breakefield, XO, Krichevsky, AM (2008-11-04). "miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells". Cancer Cell 14 (5): 382–93. doi:10.1016/j.ccr.2008.10.005. PMC 2597164. PMID 18977327.
- ↑ Tay, Y; Zhang, J, Thomson, AM, Lim, B, Rigoutsos, I (2008-10-23). "MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation". Nature 455 (7216): 1124–8. doi:10.1038/nature07299. PMID 18806776.
- ↑ Yoon, AR; Gao, R, Kaul, Z, Choi, IK, Ryu, J, Noble, JR, Kato, Y, Saito, S, Hirano, T, Ishii, T, Reddel, RR, Yun, CO, Kaul, SC, Wadhwa, R (2011-06-30). "MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region". Nucleic Acids Research 39 (18): 8078–91. doi:10.1093/nar/gkr492. PMC 3185413. PMID 21724611.
External links
| ||||||||||||||